SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

Search

BioMerieux

Chiusa

SettoreSettore sanitario

119.2 2.05

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

119.2

Massimo

119.8

Metriche Chiave

By Trading Economics

Entrata

1.6M

217M

Vendite

785M

P/E

Media del settore

32.39

53.54

Rendimento da dividendi

0.77

Margine di Profitto

10.438

Dipendenti

14,147

EBITDA

161M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+10.92% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.77%

2.44%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

713M

14B

Apertura precedente

117.15

Chiusura precedente

119.2

Notizie sul Sentiment di mercato

By Acuity

38%

62%

112 / 381 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

BioMerieux Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 apr 2025, 08:49 UTC

I principali Market Mover

BioMerieux Shares Fall After Warning on Currency-Exchange Hit

Confronto tra pari

Modifica del prezzo

BioMerieux Previsione

Obiettivo di Prezzo

By TipRanks

10.92% in crescita

Previsioni per 12 mesi

Media 131 EUR  10.92%

Alto 140 EUR

Basso 125 EUR

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per BioMerieux - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

3

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

113.1 / 118.6Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

112 / 381 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo BioMerieux

bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemaseproducing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO BACT/ALERT 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction (PCR) system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated Identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST Gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDASB·R·A·H·M·S PCTTM, a specific marker of severe bacterial infections/sepsis. It also provides Biomérieux vision suite, a software that provides actionable information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE Monoplex PCR tests; NUCLISENS ranges, a product for automation of the molecular biology laboratory and extraction; EMAG system For DNA and RNA extraction; ESTREAM, an automated preparation station for samples to process PCR tests; GENE-UP and VERIFLOW ranges for detection of microorganisms for the food industry. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.